Literature DB >> 27630839

Identification of HIV Mutation as Diagnostic Biomarker through Next Generation Sequencing.

Wen Hui Shaw1, Qianqian Lin1, Zikry Zhiwei Bin Roslee Muhammad1, Jia Jun Lee2, Wei Xin Khong3, Oon Tek Ng4, Eng Lee Tan5, Peng Li6.   

Abstract

INTRODUCTION: Current clinical detection of Human immunodeficiency virus 1 (HIV-1) is used to target viral genes and proteins. However, the immunoassay, such as viral culture or Polymerase Chain Reaction (PCR), lacks accuracy in the diagnosis, as these conventional assays rely on the stable genome and HIV-1 is a highly-mutated virus. Next generation sequencing (NGS) promises to be transformative for the practice of infectious disease, and the rapidly reducing cost and processing time mean that this will become a feasible technology in diagnostic and research laboratories in the near future. The technology offers the superior sensitivity to detect the pathogenic viruses, including unknown and unexpected strains. AIM: To leverage the NGS technology in order to improve current HIV-1 diagnosis and genotyping methods.
MATERIALS AND METHODS: Ten blood samples were collected from HIV-1 infected patients which were diagnosed by RT PCR at Singapore Communicable Disease Centre, Tan Tock Seng Hospital from October 2014 to March 2015. Viral RNAs were extracted from blood plasma and reversed into cDNA. The HIV-1 cDNA samples were cleaned up using a PCR purification kit and the sequencing library was prepared and identified through MiSeq.
RESULTS: Two common mutations were observed in all ten samples. The common mutations were identified at genome locations 1908 and 2104 as missense and silent mutations respectively, conferring S37N and S3S found on aspartic protease and reverse transcriptase subunits.
CONCLUSION: The common mutations identified in this study were not previously reported, therefore suggesting the potential for them to be used for identification of viral infection, disease transmission and drug resistance. This was especially the case for, missense mutation S37N which could cause an amino acid change in viral proteases thus reducing the binding affinity of some protease inhibitors. Thus, the unique common mutations identified in this study could be used as diagnostic biomarkers to indicate the origin of infection as being from Singapore.

Entities:  

Keywords:  Disease transmission; Drug resistance; Infectious diseases; Virus detection

Year:  2016        PMID: 27630839      PMCID: PMC5020253          DOI: 10.7860/JCDR/2016/19760.8140

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  34 in total

1.  HIV-1 subtype as a determinant of disease progression.

Authors:  Daniel R Kuritzkes
Journal:  J Infect Dis       Date:  2008-03-01       Impact factor: 5.226

2.  Universal amplification, next-generation sequencing, and assembly of HIV-1 genomes.

Authors:  Astrid Gall; Bridget Ferns; Clare Morris; Simon Watson; Matthew Cotten; Mark Robinson; Neil Berry; Deenan Pillay; Paul Kellam
Journal:  J Clin Microbiol       Date:  2012-09-19       Impact factor: 5.948

Review 3.  HIV-1 reverse transcription.

Authors:  Wei-Shau Hu; Stephen H Hughes
Journal:  Cold Spring Harb Perspect Med       Date:  2012-10-01       Impact factor: 6.915

4.  Challenges for rapid molecular HIV diagnostics.

Authors:  Marco L Schito; M Patricia D'Souza; S Michele Owen; Michael P Busch
Journal:  J Infect Dis       Date:  2010-04-15       Impact factor: 5.226

Review 5.  Genotypic testing for human immunodeficiency virus type 1 drug resistance.

Authors:  Robert W Shafer
Journal:  Clin Microbiol Rev       Date:  2002-04       Impact factor: 26.132

6.  Comparison of targeted next-generation sequencing (NGS) and real-time PCR in the detection of EGFR, KRAS, and BRAF mutations on formalin-fixed, paraffin-embedded tumor material of non-small cell lung carcinoma-superiority of NGS.

Authors:  Katja Tuononen; Satu Mäki-Nevala; Virinder Kaur Sarhadi; Aino Wirtanen; Mikko Rönty; Kaisa Salmenkivi; Jenny M Andrews; Aino I Telaranta-Keerie; Sari Hannula; Sonja Lagström; Pekka Ellonen; Aija Knuuttila; Sakari Knuutila
Journal:  Genes Chromosomes Cancer       Date:  2013-01-30       Impact factor: 5.006

Review 7.  HIV-1 Group O Origin, Evolution, Pathogenesis, and Treatment: Unraveling the Complexity of an Outlier 25 Years Later.

Authors:  Shannon Bush; Denis M Tebit
Journal:  AIDS Rev       Date:  2015 Jul-Sep       Impact factor: 2.500

8.  Clinical evaluation of an in-house human immunodeficiency virus (HIV) genotyping assay for the detection of drug resistance mutations in HIV-1 infected patients in Singapore.

Authors:  Kuan Kiat Chew; Kah Ying Ng; Wei Xin Khong; Palvinder Kaur; Joe Kwan Yap; Arlene Chua; Mei Ting Tan; Yin Ling Koh; Koh Cheng Thoon; Yee Sin Leo; Oon Tek Ng
Journal:  Ann Acad Med Singapore       Date:  2012-12       Impact factor: 2.473

9.  Clinical evaluation of a low cost, in-house developed real-time RT-PCR human immunodeficiency virus type 1 (HIV-1) quantitation assay for HIV-1 infected patients.

Authors:  Palvinder Kaur; Wei Xin Khong; Sue Yuen Wee; Eng Lee Tan; Juergen Pipper; Evelyn Koay; Kah Ying Ng; Joe Kwan Yap; Kuan Kiat Chew; Mei Ting Tan; Yee Sin Leo; Masafumi Inoue; Oon Tek Ng
Journal:  PLoS One       Date:  2014-03-06       Impact factor: 3.240

10.  Whole-genome enrichment and sequencing of Chlamydia trachomatis directly from clinical samples.

Authors:  Mette T Christiansen; Amanda C Brown; Samit Kundu; Helena J Tutill; Rachel Williams; Julianne R Brown; Jolyon Holdstock; Martin J Holland; Simon Stevenson; Jayshree Dave; C Y William Tong; Katja Einer-Jensen; Daniel P Depledge; Judith Breuer
Journal:  BMC Infect Dis       Date:  2014-11-12       Impact factor: 3.090

View more
  1 in total

Review 1.  Recent trends in molecular diagnostics of yeast infections: from PCR to NGS.

Authors:  Toni Gabaldón
Journal:  FEMS Microbiol Rev       Date:  2019-09-01       Impact factor: 16.408

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.